[Beijing, China – October 2025] – ICE Bioscience is pleased to announce our participation as an exhibitor at ELRIG Drug Discovery 2025, taking place on October 21–22, 2025, at the Exhibition Centre Liverpool, UK. You can find our team at Booth E09.

As one of Europe’s leading open-access conferences for the life sciences and drug discovery community, ELRIG Drug Discovery brings together over 3,000 delegates from pharma, biotech, academia, and CROs to explore the latest innovations in AI-driven discovery, cell and disease models, ‘omics technologies, oncology, and neurodegenerative research.

At Booth E09, the ICE Bioscience team will showcase our latest capabilities across:

- Comprehensive kinase profiling and screening services

- Target engagement and binding assays

- Ion channel and hERG safety evaluation platforms

- Advanced biophysics and assay development solutions

Our scientists and business development team will be on-site to discuss how ICE Bioscience can support your early-stage drug discovery programs through high-quality, data-driven CRO services.

We look forward to meeting partners, collaborators, and new friends in Liverpool and sharing our commitment to accelerating the next generation of therapeutics.

Event: ELRIG Drug Discovery 2025
Date: October 21–22, 2025
Location: Exhibition Centre Liverpool, UK
Booth: E09